142 related articles for article (PubMed ID: 33010027)
1. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.
Baandrup L; Faber MT; Aalborg GL; Kjaer SK
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
[TBL] [Abstract][Full Text] [Related]
3. Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study.
Hannibal CG; Frederiksen K; Vang R; Kurman RJ; Kjaer SK
Int J Cancer; 2020 Aug; 147(4):990-995. PubMed ID: 31930502
[TBL] [Abstract][Full Text] [Related]
4. Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study.
Guleria S; Jensen A; Kjær SK
Gynecol Oncol; 2018 Jan; 148(1):86-90. PubMed ID: 29174556
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007.
Kalapotharakos G; Högberg T; Bergfeldt K; Borgfeldt C
Acta Obstet Gynecol Scand; 2016 Apr; 95(4):473-9. PubMed ID: 26714557
[TBL] [Abstract][Full Text] [Related]
6. Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark.
Hannibal CG; Baandrup L; Hertzum-Larsen R; Vang R; Kurman RJ; Frederiksen K; Kjaer SK
Int J Cancer; 2023 Apr; 152(7):1370-1377. PubMed ID: 36366853
[TBL] [Abstract][Full Text] [Related]
7. Non-epithelial ovarian cancer in Denmark - Incidence and survival over nearly 40 years.
Bennetsen AKK; Baandrup L; Aalborg GL; Kjaer SK
Gynecol Oncol; 2020 Jun; 157(3):693-699. PubMed ID: 32223987
[TBL] [Abstract][Full Text] [Related]
8. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
9. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
Saygili U; Uslu T; Erten O; Doğan E
Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
[TBL] [Abstract][Full Text] [Related]
10. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
11. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries.
Kjaerbye-Thygesen A; Huusom LD; Frederiksen K; Kjaer SK
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):1006-12. PubMed ID: 16167920
[TBL] [Abstract][Full Text] [Related]
12. Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996-2017.
Faber MT; Horsbøl TA; Baandrup L; Dalton SO; Kjaer SK
Gynecol Oncol; 2022 Jan; 164(1):98-104. PubMed ID: 34763941
[TBL] [Abstract][Full Text] [Related]
13. Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in Japanese females: a population-based study from 1983 to 2007 in Niigata.
Yahata T; Banzai C; Tanaka K;
J Obstet Gynaecol Res; 2012 Apr; 38(4):645-50. PubMed ID: 22381138
[TBL] [Abstract][Full Text] [Related]
14. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.
Skírnisdóttir I; Garmo H; Wilander E; Holmberg L
Int J Cancer; 2008 Oct; 123(8):1897-901. PubMed ID: 18661518
[TBL] [Abstract][Full Text] [Related]
15. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma.
Hannibal CG; Vang R; Junge J; Frederiksen K; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Jan; 144(1):174-180. PubMed ID: 27836204
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis.
Schuurman MS; Timmermans M; van Gorp T; de Vijver KKV; Kruitwagen RFPM; Lemmens VEPP; van der Aa MA
Acta Oncol; 2019 Jul; 58(7):983-989. PubMed ID: 31135241
[No Abstract] [Full Text] [Related]
17. Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study.
Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
Gynecol Oncol; 2016 Nov; 143(2):346-351. PubMed ID: 27549433
[TBL] [Abstract][Full Text] [Related]
18. [Serous and mucinous epithelial ovarian tumors--a clinicopathologic study of 116 cases].
Giurgea NL; Pitrop M; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):389-94. PubMed ID: 23077925
[TBL] [Abstract][Full Text] [Related]
19. Ovarian and tubal cancer in Denmark: an update on incidence and survival.
Gottschau M; Mellemkjaer L; Hannibal CG; Kjaer SK
Acta Obstet Gynecol Scand; 2016 Oct; 95(10):1181-9. PubMed ID: 27454324
[TBL] [Abstract][Full Text] [Related]
20. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998.
Mink PJ; Sherman ME; Devesa SS
Cancer; 2002 Dec; 95(11):2380-9. PubMed ID: 12436446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]